Diabetic Recipes
Well, it is official. The inhaled insulin Exubera is being pulled from the market by Pfizer. An ADA article reports that Pfizer took a $2.8 Billion hit to end its involvement with the sale of the drug. Doctoral and patient support, as well as profits, has been too dismal to warrant any kind of extended sale of what was seen as a breakthrough in diabetes management by many. (READ MORE)
advertisement
December 1st, 2008
Category:
| Type 1 | Type 2 | Oral Meds | Insulin & Pumps |
| Children | Food | Highs & Lows | Relationships |
| Complications | Emotions | In the News | Fitness |
| Women's Issues | Men's Issues | Real Life |
Sort by: Most Recent | Most Active
10-26-2007 9:23 AM EDT by Scott Marvel
Categories: Type 1 Type 2 Oral Meds Insulin & Pumps In the News Real Life
Tags: Exubera profits science
Views: 897
Categories: Type 1 Type 2 Oral Meds Insulin & Pumps In the News Real Life
Tags: Exubera profits science
Views: 897
| Rating (0): |
advertisement
Michelle Kowalski, a writer, editor and photography hobbiest living in Phoenix, was diagnosed with Type 2 diabetes in February 2005. In January 2008, as part of her quest to start on an insulin pump, Michelle learned that she actually has type 1 diabetes. (Read More)
Latest Posts: The Greasy Wheel | Waiting Impatiently for CGMS OK | Back to the Find-A-Doctor Drawing Board
What happens when a health writer develops a chronic illness? As Rebecca K. Abma can tell you, it turns into an obsession. Since being diagnosed with type 2 diabetes in December 2003, 90 percent of her non-work computer time is spent researching the disease and chatting with fellow diabetics. (Read More)
Latest Posts: Mail Order Madness | Dreaming of Diabetes | Superstitious
Our Other Bloggers: Kim Doty, Lindsey Guerin, Carey Potash, Julia, George Simmons, Nicole Purcell, Kerri Morrone, Andy Bell, Scott Marvel